Literature DB >> 8222680

Steady-state pharmacokinetics of dopamine in adult patients.

P Le Corre1, Y Malledant, M Tanguy, R Le Verge.   

Abstract

OBJECTIVE: To study the pharmacokinetics of dopamine in hemodynamically stable adult patients.
DESIGN: Prospective clinical study.
SETTING: University hospital intensive care unit. PATIENTS: Fourteen patients (aged 43 to 73 yrs) recovering from esophageal surgery. INTERVENTION: Dopamine was infused and blood samples were collected.
MEASUREMENTS AND MAIN RESULTS: Plasma dopamine concentrations were measured at steady state and subsequently at the end of the dopamine infusion using high-performance liquid chromatography. Clearances, volume of distribution, mean residence times, half-lives, and elimination and distribution rate constants were derived. The clearances were independent of the infusion rate at 1, 3, and 6 micrograms/kg/min, and ranged between 0.050 and 0.056 L/min/kg. A two-compartment open model was fitted to the postinfusion plasma concentration data obtained at 3 and 6 micrograms/kg/min. On average, the steady-state volume of distribution and the apparent terminal elimination half-life increased with the dose: 0.78 to 1.58 L/kg, respectively, and 22.1 to 37.9 mins, respectively, for the rates of 3 and 6 micrograms/kg/min. The rate constant associated with the uptake of dopamine into the peripheral compartment (K12) was on average four to five times higher than the rate constant associated with the reverse process (K21).
CONCLUSIONS: The redistribution of dopamine into the central compartment could be the main factor involved in the apparent terminal elimination of dopamine from plasma. Due to the relative rates of distribution and elimination, the attainment of a steady-state plasma concentration of dopamine should only depend on the terminal half-life. These results, which remain to be validated in a greater number of patients, indicate that the attainment of 90% of the plateau (i.e., in 3.3 half-lives) would require 70 to 125 mins, depending on the infusion rate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8222680     DOI: 10.1097/00003246-199311000-00013

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  8 in total

1.  Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines.

Authors:  T Lherm; G Troché; M Rossignol; P Bordes; J F Zazzo
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

Review 2.  [Effects of dopamine on cellular and humoral immune responses in septic patients].

Authors:  G Beck; C Hanusch; P Brinkkoetter; N Rafat; J Schulte; K van Ackern; B Yard
Journal:  Anaesthesist       Date:  2005-10       Impact factor: 1.041

Review 3.  Pharmacokinetics of drugs used in critically ill adults.

Authors:  B M Power; A M Forbes; P V van Heerden; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

4.  Allosteres to regulate neurotransmitter sulfonation.

Authors:  Kristie Darrah; Ting Wang; Ian Cook; Mary Cacace; Alexander Deiters; Thomas S Leyh
Journal:  J Biol Chem       Date:  2018-12-13       Impact factor: 5.157

Review 5.  Pharmacokinetics and pharmacodynamics of intravenous inotropic agents.

Authors:  Lasse A Lehtonen; Saila Antila; Pertti J Pentikäinen
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

6.  Pharmacokinetics and pharmacodynamics of dopamine and norepinephrine in critically ill head-injured patients.

Authors:  Andrew J Johnston; Luzius A Steiner; Mark O'Connell; Dot A Chatfield; Arun K Gupta; David K Menon
Journal:  Intensive Care Med       Date:  2003-10-29       Impact factor: 17.440

Review 7.  Clinical review: immunomodulatory effects of dopamine in general inflammation.

Authors:  Grietje Ch Beck; Paul Brinkkoetter; Christine Hanusch; Jutta Schulte; Klaus van Ackern; Fokko J van der Woude; Benito A Yard
Journal:  Crit Care       Date:  2004-06-03       Impact factor: 9.097

Review 8.  A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock.

Authors:  Aditi Shankar; Gayathri Gurumurthy; Lakshmi Sridharan; Divya Gupta; William J Nicholson; Wissam A Jaber; Saraschandra Vallabhajosyula
Journal:  Clin Med Insights Cardiol       Date:  2022-02-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.